Ezetimibe
40 NDCs across 17 manufacturers|39 Generic,1 Brand
Ezetimibe is used to treat hypercholesterolemia, familial combined hyperlipidemia and hyperlipoproteinemia type II, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on Oct 25, 2002, and the first generic was approved Jun 26, 2015. FDA's Orange Book lists 13 AB-rated (therapeutically equivalent) products for this ingredient. In 2024, Medicare Part D spent $215 million on Ezetimibe across 8.8 million claims for 2.4 million beneficiaries.
Ezetimibe is available as 40 NDCs from 17 manufacturers (39 generic, 1 brand), with NADAC prices from $0.07 to $13.96 per EA — the most expensive product costs about 208× the cheapest. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
40
39G / 1B
Manufacturers
17
competing in market
Price Spread
$0.07 – $13.96
per EA
7d Activity
avg +0.4% WoW · of 40 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Manufacturer Breakdown
17 manufacturers producing EZETIMIBE(5 pricing outliers)
Frequently Asked Questions
What is Ezetimibe used to treat?
Ezetimibe is used to treat hypercholesterolemia, familial combined hyperlipidemia and hyperlipoproteinemia type II, per the National Library of Medicine's MED-RT classification.
When did Ezetimibe become available as a generic?
FDA approved the first generic Ezetimibe (ANDA) on Jun 26, 2015. The Orange Book currently lists 13 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.
How much does Medicare spend on Ezetimibe?
In 2024, Medicare Part D spent $215 million on Ezetimibe across 8.8 million claims for 2.4 million beneficiaries.
How many Ezetimibe products are on the market?
The Ezetimibe drug market contains 40 NDCs from 17 manufacturers — 39 generic and 1 brand product.
What is the price range for Ezetimibe?
NADAC reference prices for Ezetimibe range from $0.0672 to $13.9642 per EA — the most expensive product costs about 208× the cheapest.
Is generic Ezetimibe cheaper than brand?
The average generic NADAC for Ezetimibe is $0.0691 per EA, versus $13.9642 for brand-labeled products — brand versions average about 202× the generic price.
Which manufacturers make Ezetimibe?
17 manufacturers list Ezetimibe in NADAC. Ranked by number of NDCs, the largest are Amneal Pharmaceuticals NY LLC (3), Sandoz Inc. (3), Camber Pharmaceuticals Inc. (3), ScieGen Pharmaceuticals Inc. (3), Ohm Laboratories Inc. (3).
How has the price of Ezetimibe changed recently?
Over the past 7 days, 31 Ezetimibe NDCs rose and 1 fell, with a market-wide average change of +0.4%.